Impact Factor 3.644 | CiteScore 3.4
More on impact ›

Correction ARTICLE

Front. Endocrinol., 09 April 2019 | https://doi.org/10.3389/fendo.2019.00241

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status

Yu-Tang Chin1,2, Zong-Rong He3,4, Chi-Long Chen5, Hsiao-Ching Chu6, Yih Ho1,7, Po-Yu Su8, Yu-Chen S. H. Yang9, Kuan Wang1,8, Ya-Jung Shih1,8, Yi-Ru Chen1,8, Jens Z. Pedersen10, Sandra Incerpi11, André Wendindondé Nana12, Heng-Yuan Tang13, Hung-Yun Lin1,12,13,14,15*, Shaker A. Mousa13, Paul J. Davis13,16 and Jacqueline Whang-Peng1,2,12*
  • 1Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
  • 2Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
  • 3Department of Pediatrics, E-Da Hospital, Kaohsiung, Taiwan
  • 4School of Medicine, I-Shou University, Kaohsiung, Taiwan
  • 5School of Medicine, Taipei Medical University, Taipei, Taiwan
  • 6Division of Medical Imaging, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan
  • 7School of Pharmacy, Taipei Medical University, Taipei, Taiwan
  • 8Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
  • 9Joint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan
  • 10Department of Biology, University of Rome Tor Vergata, Rome, Italy
  • 11Department of Sciences, Roma Tre University, Rome, Italy
  • 12Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
  • 13Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States
  • 14TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan
  • 15Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
  • 16Department of Medicine, Albany Medical College, Albany, NY, United States

A Corrigendum on
Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status

by Chin, Y.-T., He, Z.-R., Chen, C.-L., Chu, H.-C., Ho, Y., Su, P.-Y, et al. (2019). Front. Endocrinol. 10:130. doi: 10.3389/fendo.2019.00130

In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: perfusion bellows cell culture system, colorectal cancer cells, anticancer, phosphoERK1/2, NDAT, tetrac, integrin αvβ3

Citation: Chin Y-T, He Z-R, Chen C-L, Chu H-C, Ho Y, Su P-Y, Yang Y-CSH, Wang K, Shih Y-J, Chen Y-R, Pedersen JZ, Incerpi S, Nana AW, Tang H-Y, Lin H-Y, Mousa SA, Davis PJ and Whang-Peng J (2019) Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Front. Endocrinol. 10:241. doi: 10.3389/fendo.2019.00241

Received: 26 March 2019; Accepted: 27 March 2019;
Published: 09 April 2019.

Approved by: Frontiers in Endocrinology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Chin, He, Chen, Chu, Ho, Su, Yang, Wang, Shih, Chen, Pedersen, Incerpi, Nana, Tang, Lin, Mousa, Davis and Whang-Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hung-Yun Lin, linhy@tmu.edu.tw
Jacqueline Whang-Peng, jqwpeng@nhri.org.tw

These authors have contributed equally to this work